Masaki Yoshida
- Urology top 0.05%
- Rheumatology top 0.5%
- Epidemiology top 5%
- Endocrinology, Diabetes and Metabolism top 1%
- Molecular Biology
- Co-authors
- Yukio HommaMomokazu GotohOsamu YokoyamaShoichi UedaOsamu YamaguchiMasayuki TakedaOsamu NishizawaKazuki Kawabe
- Topics
- Urinary Bladder and Prostate Research (69 papers)Pelvic floor disorders treatments (30 papers)Urinary Tract Infections Management (30 papers)
- Partner nations
- JapanUnited StatesFrance
In The Last Decade
Masaki Yoshida
136 papers receiving 4.1k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Urology 2.3k
- Rheumatology 1.5k
- Epidemiology 923
- Endocrinology, Diabetes and Metabolism 781
- Molecular Biology 666
Countries citing papers authored by Masaki Yoshida
This map shows the geographic impact of Masaki Yoshida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaki Yoshida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaki Yoshida more than expected).
Fields of papers citing papers by Masaki Yoshida
This network shows the impact of papers produced by Masaki Yoshida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaki Yoshida. The network helps show where Masaki Yoshida may publish in the future.
Co-authorship network of co-authors of Masaki Yoshida
This figure shows the co-authorship network connecting the top 25 collaborators of Masaki Yoshida. A scholar is included among the top collaborators of Masaki Yoshida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaki Yoshida. Masaki Yoshida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 2 | |
| 3 | 0 | |
| 4 | Intravesical application of rebamipide suppresses bladder inflammation and overactivity in a rat model | 1 |
| 5 | Clinical outcomes of imidafenacin in addition to tamsulosin for patients with overactive bladder and benign prostatic hyperplasia (Addition study) | 1 |
| 6 | 25 | |
| 7 | 32 | |
| 8 | 9 | |
| 9 | 15 | |
| 10 | PREDICTIVE FACTORS FOR THE EFFECT OF ALPHA1- ADRENOCEPTOR ANTAGONIST ON SUBJECTIVE AND OBJECTIVE PARAMETERS IN PATIENTS WITH NEUROGENIC LOWER URINARY TRACT DYSFUNCTION: SPECIAL FOCUS ON ALPHA1-D/A ADRENOCEPTOR ANTAGONIST NAFTOPIDIL | 1 |
| 11 | 214 | |
| 12 | 18 | |
| 13 | 7 | |
| 14 | 45 | |
| 15 | 1 | |
| 16 | 23 | |
| 17 | 39 | |
| 18 | 2 | |
| 19 | Effect of T-3262 and its structural derivatives on GABA receptor binding | 5 |
| 20 | 2 |
About Masaki Yoshida
Masaki Yoshida is a scholar working on Urology, Rheumatology and Endocrinology, Diabetes and Metabolism, having authored 143 papers that have together received 4.2k indexed citations. Recurring topics across this work include Urinary Bladder and Prostate Research (69 papers), Pelvic floor disorders treatments (30 papers) and Urinary Tract Infections Management (30 papers). The work is most often cited by research in Urology (2.3k citations), Rheumatology (1.5k citations) and Clinical Biochemistry (488 citations). Masaki Yoshida has collaborated with scholars based in Japan, United States and France. Frequent co-authors include Yukio Homma, Momokazu Gotoh, Osamu Yokoyama, Shoichi Ueda, Osamu Yamaguchi, Masayuki Takeda, Osamu Nishizawa, Kazuki Kawabe, Tomonori Yamanishi and Hidehiro Κakizaki. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.